PharmGKB summary: fluoropyrimidine pathways.
Thorn
Caroline F
CF
Department of Genetics, Stanford University Medical Center, Stanford, California, USA.
Marsh
Sharon
S
Carrillo
Michelle Whirl
MW
McLeod
Howard L
HL
Klein
Teri E
TE
Altman
Russ B
RB
D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics*; D000069287:Capecitabine; D016208:Databases, Factual; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D015894:Genome, Human; D006801:Humans; D010597:Pharmacogenetics; D005641:Tegafur / Q000493:pharmacokinetics
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D005641:Tegafur; D000069287:Capecitabine; D005472:Fluorouracil